After finishing at $13.87 in the prior trading day, Elanco Animal Health Inc (NYSE: ELAN) closed at $13.64, down -1.66%. On the day, 4297933 shares were traded.
Ratios:
Our goal is to gain a better understanding of ELAN by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 19.10 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 51.33. For the most recent quarter (mrq), Quick Ratio is recorded 1.35 and its Current Ratio is at 2.75. In the meantime, Its Debt-to-Equity ratio is 0.95 whereas as Long-Term Debt/Eq ratio is at 0.94.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Stifel on January 05, 2024, Upgraded its rating to Buy and sets its target price to $20 from $13 previously.
On December 19, 2023, Jefferies started tracking the stock assigning a Buy rating and target price of $17.
Morgan Stanley Upgraded its Equal-Weight to Overweight on December 15, 2023, while the target price for the stock was maintained at $16.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 08 ’24 when DOYLE WILLIAM F bought 15,000 shares for $16.30 per share. The transaction valued at 244,500 led to the insider holds 61,330 shares of the business.
Harrington Michael J bought 3,100 shares of ELAN for $50,494 on Mar 08 ’24. The Director now owns 77,594 shares after completing the transaction at $16.29 per share. On Mar 06 ’24, another insider, HOOVER R DAVID, who serves as the Director of the company, bought 20,000 shares for $16.14 each. As a result, the insider paid 322,808 and bolstered with 185,000 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 1.52 while its Price-to-Book (P/B) ratio in mrq is 1.08.
Stock Price History:
Over the past 52 weeks, ELAN has reached a high of $16.88, while it has fallen to a 52-week low of $7.88.
Shares Statistics:
A total of 492.85M shares are outstanding, with a floating share count of 488.17M. Insiders hold about 0.97% of the company’s shares, while institutions hold 98.35% stake in the company.
Earnings Estimates
Its stock is currently analyzed by Elanco Animal Health Incorporat different market analysts. The consensus estimate for the next quarter is $1.60, with high estimates of $86.00 and low estimates of $27.04.
